AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

12,050.00p
   
  • Change Today:
    -106.00p
  • 52 Week High: 12,178.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.24m
  • Volume: 1,635,158
  • Market Cap: £186,803m
  • RiskGrade: 123

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue 12,024.00 11,207.00 12,011.00 7,410.00 6,664.00
Operating Profit/(Loss) 1,234.00 1,094.00 (292.00) 1,487.00 577.00
Profit Before Tax 897.00 778.00 (636.00) 1,167.00 240.00
Profit After Tax 959.00 902.00 (346.00) 1,005.00 277.00
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD 959.00 902.00 (346.00) 1,005.00 277.00
           
Continuing EPS          
Earnings per Share - Basic 62.00¢ 58.00¢ (22.00¢) (78.00¢) 24.00¢
Earnings per Share - Diluted 62.00¢ 58.00¢ (22.00¢) (78.00¢) 24.00¢
Earnings per Share - Adjusted 62.00¢ 58.00¢ (22.00¢) (78.00¢) 89.00¢
Continuing and Discontinued EPS          
Earnings per Share - Basic 62.00¢ 58.00¢ (22.00¢) (78.00¢) 24.00¢
Earnings per Share - Diluted 62.00¢ 58.00¢ (22.00¢) (78.00¢) 24.00¢
Earnings per Share - Adjusted 62.00¢ 58.00¢ (22.00¢) (78.00¢) 89.00¢
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Total Non-Current Assets 76,065.00 73,890.00 79,119.00 47,185.00 45,814.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 101,119.00 96,483.00 105,363.00 66,729.00 61,377.00
Total Liabilities 61,953.00 59,425.00 66,076.00 51,091.00 46,781.00
Net Assets 39,166.00 37,058.00 39,287.00 15,638.00 14,596.00
           
Shareholders Funds 39,143.00 37,037.00 39,268.00 15,622.00 13,127.00
Minority Interests/Other Equity 23.00 21.00 19.00 16.00 1,469.00
Total Equity 39,166.00 37,058.00 39,287.00 15,638.00 14,596.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page